biotech
Bio-AnalystSupplement research
person

Calcium

Selected research topic

Cardiovascular events

The comparison is unconfirmed, so the findings cannot establish this ingredient’s effect.

Publications for this topic
1
Human comparison publications
0
Publications needing review
0

Findings in the studies

  • cardiovascular mortality

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: General population. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Non-linear dose-response association; lower and higher dietary intake than around 800 mg/day associa
      Additional measurement information
      Primary outcome
      Measurement time
      Long-term cohort follow-up; unspecified in abstract
Representative outcome and study details

Studies with an unspecified organism reported a change with no confirmed comparison group in cardiovascular mortality.

Scope not specified · comparator not confirmed

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 44.3 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 52

Papers linked to this topic 1 · distinct papers 1 · comparison findings need further review · papers needing additional review 0

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • cardiovascular mortality: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

cardiovascular mortality

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

abdominal discomfort1 papers
One patient experienced abdominal discomfort during calcium supplementation (500 mg/day).Human studies · Observational study

Cautions reported with another supplement or medication

These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.

당뇨병Calcium supplementation showed significant multiplicative and additive interaction with diabetes status, increasing CVD risk in diabetic individuals.